BT13 MySkinDoctor: lessons learnt from assessing 120 000 teledermatology patients

Abstract MySkinDoctor is a novel teledermatology platform that enables dermatologists to review images submitted directly by the patient via their smartphone, in addition any metadata and standard general practitioner referral. The three sets of data are used triage or provide advice guidance National Health Service patients throughout south east England. Since its inception 2019, service has completed assessment > 120 000 cases. Analysis shows an unnecessary first appointment been avoided 48% This led sharp reduction waiting times areas which it being (an average 6 weeks) vs. neighbouring where remain between 27 50 weeks. Another benefit that, on average, each using submits digital subsequently tagged inter alia with age, sex, body location consultant’s diagnosis. resulted large, growing, image library associated dataset develop artificial intelligence called ‘dermXai’. Using convolutional neural networks for identification produced accuracy determination 90% top 20 conditions seen. We will discuss implementation schedule regulatory challenges need be met order dermXai support clinical decision-making. There also environmental economic benefits MySkinDoctor. inception, saved 40 road miles—over twice Earth’s circumference. CO2 saving 16 488 kg. carers terms travel regaining otherwise lost productivity time difficult quantify but could studied prospectively. Patient-led dermatology obvious evolution traditional our successful experience southern England provides template national eliminate backlogs significantly reduce times. Conflicts interest: Dr Bav Shergill Chief Medical Officer Ltd Director dermXai.